Overview
CSOFT International is a premier provider of globalization and localization solutions, positioning itself in 2026 as a leader in AI-human hybrid translation workflows. The company’s technical architecture revolves around its 'Stepes' platform—a mobile-first, cloud-based translation ecosystem that integrates Neural Machine Translation (NMT) with a global network of over 10,000 certified linguists. CSOFT specializes in highly regulated sectors, specifically Life Sciences (via CSOFT Health Sciences), MedTech, and Global Finance. Their 2026 market position focuses on 'Regulatory AI,' where they utilize Large Language Models (LLMs) to ensure compliance with shifting international standards like the EU MDR/IVDR and global clinical trial requirements. By utilizing a proprietary 'AI-First, Human-Final' approach, CSOFT optimizes the localization lifecycle, reducing time-to-market for complex software and medical documentation. Their technical stack includes automated Terminology Management Systems (TMS), Translation Memory (TM) leveraging vector databases, and seamless API integrations into modern CI/CD pipelines for software companies.